Kiora Pharmaceuticals
KPRX
5 hedge funds and large institutions have $1.06M invested in Kiora Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.03M |
| 2 |
AIC
AWM Investment Company
New York
|
+$458K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$45.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$22.9K |
| 5 |
VIA
Vantage Investment Advisors
State College,
Pennsylvania
|
+$22.9K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $695K | +$1.03M | +45 | New |
|
|
AIC
2
AWM Investment Company
New York
| $304K | +$458K | +20 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $28K | +$45.8K | +2 | New |
|
|
VIA
4
Vantage Investment Advisors
State College,
Pennsylvania
| $19K | +$22.9K | +1 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $11K | +$22.9K | +1 | New |
|
6
Morgan Stanley
New York
| $3K | – | – | – |
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | – | – | – |
|
KPRX Hedge Fund Activity: Q3 2015 in Review
5 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Kiora Pharmaceuticals (KPRX) for Q3 2015, worth a combined $1.06M.
Buyers outnumbered sellers: 5 funds opened new KPRX positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.03M.
- 5 institutional investors held Kiora Pharmaceuticals (KPRX) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $1.06M of Kiora Pharmaceuticals stock for Q3 2015.
- 5 funds opened new Kiora Pharmaceuticals positions in Q3 2015 and 0 closed out, a net change of +5 holders.
- The largest Kiora Pharmaceuticals buyer in Q3 2015 was Sabby Management, an estimated $1.03M added.
Based on aggregated 13F filings for Q3 2015.